Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

Two hundred patients with rheumatoid arthritis were studied in a prospective open trial comparing treatment with sulphasalazine and auranofin in patients with active disease over 12 months. The two drugs improved many parameters of disease activity at 12, 24, and 48 weeks. At 12 weeks, the group tre...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	Ann Rheum Dis
Asıl Yazarlar:	Porter, D, Madhok, R, Hunter, J A, Capell, H A
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMJ Publishing Group 1992
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004691/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1350192/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.51.4.461
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!